Nolvadex also knowns as Tamoxifen is a SERM that Global Pharma manufacturers. It is essentially a selective estrogen receptor modulator that is used by athletes to combat gynecomastia which several anabolic steroids can cause, such as Testosterone and Dianabol.  It also used as a part of Post Cycle Therapy in order to help recover natural hormone levels after a Steroid or SARM cycle. So this chemical is used either during a cycle for the purpose of combating estrogen-induced side effects or after a cycle to assist in recovery.

Nolvadex use during a cycle

The most common dose that bodybuilders and athletes use is 20mg per day. This seems to be efficient as stopping the formation of gynecomastia during a cycle. It is important to note that Nolvadex will only stop gynecomastia if it is being caused by estrogen. It will not stop gynecomastia if the culprit is something other than estrogen.

There is also a big misconception in the Canadian bodybuilding/performance-enhancing world that Nolvadex is an anti-estrogen. Nolvadex does not actually lower estrogen at all. It merely stops estrogen from binding to the nipple receptors, hence why it is able to stop the formation of gynecomastia that would be induced by estrogen.

Nolvadex use during post cycle therapy

A post cycle therapy is absolutely imperative after a Steroid or SARM cycle in order to ensure adequate recovery. Nolvadex is an extremely effective compound for assisting in recovery and doses between 20-40mg per day are very common.

A sample post cycle therapy stack with Nolvadex is:

Nolvadex dosed at 40mg per day for the first 2 weeks, followed by Nolvadex dosed at 20mg per day for the last 2 weeks. The total duration being 4 weeks.

Buying Nolvadex

Nolvadex is not a very expensive compound, but it is an extremely important one. Global Pharmaceuticals is able to provide Canadians with a high quality Nolvadex product.


There are no reviews yet.

Be the first to review “GLOBAL PHARMA – NOLVADEX 20MG”

Your email address will not be published. Required fields are marked *